[1] GERAGHTY J. Adenomatous polyposis coli and

translational medicine[J]. Lancet，1996，348（9025）：

422.

[2] MEI T，KIM A，VONG L B，et al. Encapsulation

of tissue plasminogen activator in pH-sensitive selfassembled

antioxidant nanoparticles for ischemic

stroke treatment - Synergistic effect of thrombolysis

and antioxidant[J/OL]. Biomaterials，2019，215：

119209[2019-11-10]. https：//doi.org/10.1016/

j.biomaterials.2019.05.020.

[3] DIRKS M，NIESSEN L W，VAN WIJNGAARDEN

J D，et al. Promoting thrombolysis in acute ischemic

stroke[J]. Stroke，2011，42（5）：1325-1330.

[4] SMITH M，REDDY U，ROBBA C. Acute ischaemic

stroke：challenges for the intensivist[J]. Intens Care

Med，2019，45（9）：1177-1189.

[5] JIAN Z，LIU R，ZHU X，et al. The involvement

and therapy target of immune cells after ischemic

stroke[J/OL]. Front Immunol，2019，10：2167[2019-

11-10]. https：//doi.org/10.3389/fimmu.2019.02167.

[6] FLURI F，SCHUHMANN M K，KLEINSCHNITZ

C. Animal models of ischemic stroke and their

application in clinical research[J]. Drug Des Devel

Ther，2015，9：3445-3454.

[7] FODDIS M，WINEK K，BENTELE K，et al.

An exploratory investigation of brain collateral

circulation plasticity after cerebral ischemia in two

experimental C57BL/6 mouse models[J]. J Cerebr

Blood F Met，2020，40（2）：276-287.

[8] WELLS A J，VINK R，HELPS S C，et al. Elevated

intracranial pressure and cerebral edema following

permanent MCA occlusion in an ovine model[J/OL].

PLoS One，2015，10（6）：e0130512[2019-11-10].

https：//doi.org/10.1371/journal.pone.0130512.

[9] LEE J H，JONES C F，OKON E B，et al. A novel

porcine model of traumatic thoracic spinal cord

injury[J]. J Neurotrauma，2013，30（3）：142-159.

[10] CHAUHAN A，MOSER H，MCCULLOUGH L

D. Sex differences in ischaemic stroke：potential

cellular mechanisms[J]. Clin Sci（Lond），2017，131

（7）：533-552.

[11] CARRASQUILLA G D，FRUMENTO P，

BERGLUND A，et al. Postmenopausal hormone

therapy and risk of stroke：a pooled analysis of data

from population-based cohort studies[J/OL]. PLoS

Med，2017，14（11）：e1002445[2019-11-10]. https：//

doi.org/10.1371/journal.pmed.1002445.

[12] GRIEMERT E V，RECARTE PELZ K，

ENGELHARD K，et al. PAI-1 but not PAI-2 gene

deficiency attenuates ischemic brain injury after

experimental stroke[J]. Transl Stroke Res，2019，10

（4）：372-380.

[13] MCCABE C，ARROJA M M，REID E，et al. Animal

models of ischaemic stroke and characterisation of

the ischaemic penumbra[J]. Neuropharmacology，

2018，134（Pt B）：169-177.

[14] ALLRED R P，ADKINS D L，WOODLEE M T，et

al. The vermicelli handling test：a simple quantitative

measure of dexterous forepaw function in rats[J]. J

Neurosci Methods，2008，170（2）：229-244.

[15] CORDOVA C A，JACKSON D，LANGDON K D，et

al. Impaired executive function following ischemic

stroke in the rat medial prefrontal cortex[J]. Behav

Brain Res，2014，258：106-111.

[16] CRAMER S C，KOROSHETZ W J，FINKLESTEIN

S P. The case for modality-specific outcome

measures in clinical trials of stroke recoverypromoting

agents[J]. Stroke，2007，38（4）：1393-

1395.

[17] BUSHNELL C，BETTGER J P，COCKROFT

K M，et al. Chronic stroke outcome measures

for motor function intervention trials：expert

panel recommendations[J]. Circ Cardiovasc Qual

Outcomes，2015，8（6 Suppl 3）：S163-S169.

[18] HILL M D. Stroke：the dashed hopes of

neuroprotection[J]. Lancet Neurol，2007，6（1）：2-3.

[19] ELKINS J，VELTKAMP R，MONTANER J，et al.

Safety and efficacy of natalizumab in patients with

acute ischaemic stroke（ACTION）：a randomised，

placebo-controlled，double-blind phase 2 trial[J].

Lancet Neurol，2017，16（3）：217-226.

[20] AVERT Trial Collaboration group. Efficacy and

safety of very early mobilisation within 24 h of

stroke onset（AVERT）：a randomised controlled

trial[J]. Lancet，2015，386（9988）：46-55.

[21] HILL M D，MARTIN R H，MIKULIS D，et

al. Safety and efficacy of NA-1 in patients with

iatrogenic stroke after endovascular aneurysm repair （ENACT）：a phase 2，randomised，double-blind，

placebo-controlled trial[J]. Lancet Neurol，2012，11

（11）：942-950.

[22] XU L J，OUYANG Y B，XIONG X，et al. Poststroke

treatment with miR-181 antagomir reduces

injury and improves long-term behavioral recovery

in mice after focal cerebral ischemia[J]. Exp Neurol，

2015，264：1-7.

[23] KIM T，MEHTA S L，KAIMAL B，et al. Poststroke

induction of alpha-synuclein mediates ischemic brain

damage[J]. J Neurosci，2016，36（26）：7055-7065.

[24] YIN K J，OLSEN K，HAMBLIN M，et al. Vascular

endothelial cell-specific microRNA-15a inhibits

angiogenesis in hindlimb ischemia[J]. J Biol Chem，

2012，287（32）：27055-27064.

[25] CHEVILLEY A，LESEPT F，LENOIR S，et al.

Impacts of tissue-type plasminogen activator（tPA）

on neuronal survival[J/OL]. Front Cell Neurosci，

2015，9：415[2019-11-10]. https：//doi.org/10.3389/

fncel.2015.00415.